Business Context and Reporting Period
AmpliTech Group, Inc. (Nasdaq: AMPG) filed a Form 8-K on April 24, 2025, reporting an unregistered sale of equity securities. The filing details the execution of an asset purchase agreement (APA) with Titan Crest, LLC, a Delaware limited liability company.
Key Financial Metrics and Transaction Details
- Transaction Type: Unregistered sale of restricted common stock as partial consideration for an asset acquisition.
- Shares Issued: 914,635 shares of restricted common stock.
- Issuance Price: $1.64 per share (based on the 30-day volume-weighted average price).
- Value of Equity Issued: Approximately $1,500,000.
- Total Purchase Price: $8,000,000 aggregate for the assets.
- Payment Structure:
- Cash: $4,000,000 total ($3,500,000 paid as of April 24, 2025).
- Equity: $4,000,000 total ($1,500,000 issued as of April 24, 2025).
- Regulatory Basis: Issued under Section 4(a)(2) and/or Rule 506 exemptions; recipient represented as an accredited investor.
Material Changes and Milestones
The issuance was triggered by the achievement of the "First Milestone" under the APA, originally dated March 26, 2025, and amended on April 15, 2025. The transaction represents a material change in the company's capital structure and asset base. A second milestone is expected to be achieved toward the end of the year, which will trigger the issuance of the remaining equity and cash payments.
Outlook and Risks
The filing does not provide specific financial guidance, revenue projections, or management commentary beyond the transaction mechanics. The primary contingency noted is the achievement of the second milestone, which is required to finalize the remaining $2,500,000 in cash and $2,500,000 in equity consideration. The filing text does not provide clear values for the company's overall revenue, profit, cash flow, or debt levels outside of this specific transaction.
Investor Verification Checklist
- Verify the specific assets acquired from Titan Crest, LLC and their expected contribution to future revenue.
- Confirm the criteria and timeline for the "second milestone" to assess future dilution and cash outflow.
- Review the amended Asset Purchase Agreement (dated April 15, 2025) for any additional covenants or conditions.
- Assess the impact of the $3.5 million cash outflow on the company's current liquidity position.